Our two-fold mission is to improve the quality of human life through creative basic and translational research in cardiovascular disease, and to build a legacy of outstanding scholarship, scientific achievement, and therapeutic discovery.  We will accomplish our mission by providing a challenging, results-oriented environment for training and developing future generations of researchers and physician-scientists.

Recent News

March 31, 2008

Feinberg Cardiovascular Research Institute Teams Win 2nd and 3rd Place Prizes for Poster Presentations at the Fourth Annual Lewis Landsberg Research Day

Researchers from Feinberg Cardiovascular Research Institute won the 2nd and 3rd place prizes in the basic science competition at the Fourth Annual Lewis Landsberg Research Day, held on March 19, 2008 at Northwestern University.

Min Cheng, working under the direction of Dr. Gangjian Qin, won the 2nd Place Prize in the basic science competition for her poster entitled "Alpha4 Integrin Modulates the Functional Status of c-kit in Bone Marrow Stem Cell Niche".

	Click to view poster.
Min Cheng with Dr. L. Larry Jameson, Dean, Feinberg School of Medicine

Rongxu Wu and Mike Burke, working under the direction of Dr. Hossein Ardehali, won the 3rd Place Prize in the basic science competition for their poster entitled "Cytoprotective role of mitochondrial ATP-binding cassette protein-2".

	Click to view poster.
From left: Rongxu Wu, Mike Burke, Teja Naik, and Hossein Ardehali

Douglas W. Losordo, MD
Director, Feinberg Cardiovascular Research Institute

On behalf of the faculty and staff of the Feinberg Cardiovascular Research Institute, I welcome you to our Web site and thank you for your interest in learning about our programs.

Originally established in 1988, the Feinberg Cardiovascular Research Institute is dedicated to pursuing an understanding of the fundamental molecular and cellular processes underlying cardiovascular disease, the largest contributor to morbidity and mortality in the United States. Though tremendous strides have been made in recent years in our understanding and treatment of cardiovascular disease, much work remains to be done.

Our investigators at Feinberg Cardiovascular Research Institute are exploring complex problems at the vanguard of modern cardiovascular research, including basic cellular signalling pathways and their contributions to disease, the use of stem cells in regenerative medicine, and diagnostic and imaging technologies critical to patient care.

As our Institute grows and evolves, we will continue to build expertise and infrastructure to support translational research, providing a more productive route for transforming basic laboratory discoveries into new treatment options for patients.